Cardialen takes in $17 mln Series B

Minneapolis-based Cardialen Inc, a medical device company, has raised $17 million in Series B funding. RiverVest Venture Partners led the round with participation from Qiming Venture Partners, HBM Healthcare Investments and Cultivation Capital.

10 October 2018•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail